贝伐单抗在肝癌治疗中的应用现状及进展Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma
钱坤, 钱骏
医学诊断Vol.1 No.1, 全文下载: PDF HTML XML DOI:10.12677/md.2011.11001, September 28 2011
肝动脉灌注化疗在中晚期肝癌联合治疗中的作用The Role of Hepatic Arterial Infusion Chemotherapy in the Combination Therapy of Advanced Hepatocellular Carcinoma
苏 涛, 孙 航, 吴传新 国家自然科学基金支持
临床医学进展Vol.12 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.123271, March 17 2022
肝动脉化疗栓塞术联合甲磺酸阿帕替尼片治疗晚期肝癌的疗效及安全性评价Efficacy and Safety of Transarterial Chemoembolization Combined with Apatinib Mesylate in Patients with Advanced Hepatocellular Carcinoma
秦立东, 邓庆潇, 王 楠 科研立项经费支持
临床医学进展Vol.9 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2019.911207, November 27 2019
T + A方案改善免疫微环境，实现晚期HCC优质生存Bevacizumab plus AtezolizumabImprove the Immune Microenvironment and Achieve High Quality Survival of Advanced in HCC
阿力亚·买买提吐尔逊, 张 韬
临床医学进展Vol.13 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.133695, March 30 2023
预测肝细胞癌免疫治疗的预后Biomarkers of Immunotherapy for Hepatocellular Carcinoma
王奇峰, 王海久
临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122629, December 6 2023
HBV相关肝癌的CD8+T细胞抗肿瘤免疫机制研究进展Research Progress on Anti-Tumor Immune Mechanism of CD8+T Cells in HBV-Related Hepatocellular Carcinoma
任丹丹, 马金鑫
临床医学进展Vol.11 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.115338, May 27 2021